ABcann Global Corporation Announces $70 Million Bought Deal Financing NAPANEE, ON, Jan. 29, 2018 /CNW/ – ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”) announced today that it has entered into an...
ABCANN GLOBAL CORPORATION (TSXV: ABCN) (“ABcann” or the “Company”) is pleased to announce that its wholly-owned subsidiary, ABcann Australia Pty Ltd. (“ABcann Australia”), has received an import license from...
ABcann Appoints New Chief Marketing Officer NAPANEE, Ontario, Jan. 05, 2018 (GLOBE NEWSWIRE) — ABCANN GLOBAL CORPORATION (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce the appointment of...
NAPANEE, Ontario, Jan. 02, 2018 (GLOBE NEWSWIRE) — ABCANN GLOBAL CORPORATION (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce that the Company has been licensed by Health Canada...
ABcann Global Announces Closing of $30 Million Financing NAPANEE, Ontario, Dec. 22, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”) is pleased to announce the...
NAPANEE, Ontario, Nov. 29, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”) today announces the release of its financial results for the three and nine...
ABcann Global Announces $30 Million Debenture Financing NAPANEE, Ontario, Nov. 27, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”) is pleased to announce that it...
ABcann Global Appoints New Independent Chair NAPANEE, Ontario, Oct. 17, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) today announces that Ken Clement, founder and...
ABcann Global Receives $11.9 Million from Exercise of Warrants NAPANEE, Ontario, Sept. 18, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is...
ABcann Global Appoints Barry Fishman as Chief Executive Officer NAPANEE, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is...
OTTAWA, Aug. 29, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to release the Company’s financial results for the three and six months...
ABcann Releases High Level CBD Product and Launches Initial Oils Strategy OTTAWA, Aug. 28, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (“ABcann” or the “Company”) is pleased...
ABcann and Cannabis Wheaton Announce Closing of $15 Million Investment OTTAWA, Aug. 02, 2017 (GLOBE NEWSWIRE) — Further to their joint news release dated July 10, 2017, ABcann Global...
ABcann Global Provides Construction and Expansion Update OTTAWA, July 26, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (Frankfurt: 23Q) (OTCQB: ABCCF) (the “Company”) is pleased to provide...
ABcann Global Announces Listing on the OTCQB Marketplace and the Frankfurt Stock Exchange OTTAWA, July 12, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or...
ABcann and Cannabis Wheaton Announce Signing of Agreement for First Tranche $15 Million Investment OTTAWA, July 10, 2017 (GLOBE NEWSWIRE) — Further to their joint news release dated May...
OTTAWA, July 05, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is pleased to announce its inclusion in the Horizons Medical Marijuana...
OTTAWA, June 29, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is pleased to announce that it has retained the services of...
OTTAWA, June 26, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is pleased to announce that it has amended and extended the research...
ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility VANCOUVER, BC–(Marketwired – May 29, 2017) – ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF)...
ABcann Extends Agreement With Medical Cannabis Pioneer OTTAWA, May 09, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that Raphael Mechoulam has agreed...
ABcann Global Announces Appointment of W. Brett Wilson to Advisory Board NAPANEE, Ontario, May 04, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce...
ABcann Global Announces Closing of Qualifying Transaction and Concurrent Financings NAPANEE, Ontario, May 03, 2017 (GLOBE NEWSWIRE) — ABCANN GLOBAL CORPORATION (TSXV: ABCN) (formerly Panda Capital Inc.) (“ABcann” or...
Panda and ABcann Medicinals Announce Multi-Stage Product Testing Methodology OTTAWA, April 24, 2017 (GLOBE NEWSWIRE) — Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce details of the...
In advance of ABcann Global (TSXV: ABCN) trading publicly in the very near future, we hosted CEO Aaron Keay to discuss the company. Keay began by reviewing the corporate...
